Chemokine receptors are G protein-coupled receptors which contain seven transmembrane domains. pharmaceutical importance against the modeled receptors. Analysis of interaction modes gave an integrated interpretation with detailed structural information. The binding poses confirmed that the acidic residues CH5132799 Glu291 (CCR2) and Glu283 (CCR5) are important, and we also found some additional residues. Comparisons of binding sites of CCR2/CCR5 were done sequentially and also by docking a potent dual antagonist. Our results can be a starting point for further structure-based drug design. Introduction Chemokines are small (8C10 kDa) water-soluble proteins consisting of 340C380 amino acid residues, which play key roles in immuno-modulation and host defense. They selectively recruit monocytes, neutrophils, and lymphocytes to sites of vascular injury and inflammation [1]C[3]. Different chemokines produce various leukocyte responses depending on the complementary nature of their chemokine receptors [4], [5]. The basic feature of inflammation is the CH5132799 tissue recruitment of leukocytes, which is mediated mainly by chemokines (chemotactic cytokines) via their receptors. The chemokine super family can be categorized into four groups Pik3r2 (CC, CXC, CX3C, and C), according to the number and spacing of conserved cysteines in the amino acid sequence [6]C[9]. Apart from their well-recognized role in leukocyte recruitment, some chemokines CH5132799 and chemokine receptors play crucial roles in other cellular functions such as activation, proliferation, and differentiation [6]C[9]. Particular family get excited about viral entry and angiogenesis [9] also. It had been reported that also, a subset of chemokine receptors takes on a nonredundant part in infectious illnesses, as proven by level of resistance to human being immunodeficiency pathogen/obtained immunodeficiency symptoms (HIV/Helps) in people homozygous for CCR5 32 (a lack of function mutation) [10]C[14]. For their diverse selection of essential functions, chemokines have already been targeted as potential factors of pharmaceutical treatment for illnesses as varied as asthma, arthritis rheumatoid, multiple sclerosis, solid body organ transplantation, atherosclerosis, tumor, and HIV disease [9]. Since these chemokine receptors are G protein-coupled receptors and targeted for varied illnesses, many pharmaceutical and biotechnology businesses have devoted tremendous time, work, and expenditure in developing powerful small-molecule chemokine antagonists [15], [16]. Appropriately, usage of two such antagonists, Maraviroc (a CCR5 antagonist) for the treating HIV/Helps [17] and Plerixafor (a CXCR4 antagonist) found in mixture with granulocyte-colony stimulating element (G-CSF) to mobilize hematopoietic stem cells towards the peripheral bloodstream for collection and following autologous transplantation in individuals with non-Hodgkin’s lymphoma and multiple myeloma have already been approved by america Food and Medication Administration (FDA) [18]. But, for persistent inflammatory diseases, medical tests with antagonists of an individual chemokine receptor (e.g., CCR1, CCR2, or CCR5) never have proved effective [15], [16], which includes been a significant setback. Taking into consideration the problems of pathogenesis of the diseases as well as the prospect of practical redundancy of chemokine receptors, focusing on an individual receptor is probably not adequate for efficacy for these chronic conditions. CCR2 and CCR5 are two CC chemokine receptors that are essential players in the trafficking of monocytes/macrophages and in the features of additional cell types highly relevant to disease pathogenesis [19], [20]. Therefore, structural information of CCR5 and CCR2 can be handy and needed for providing insights on the subject of targeting these receptors. Two latest research possess reported the usage of dual antagonists focusing on both CCR5 and CCR2 [21], [22]. Computational modeling is becoming an essential device in guiding and allowing rational decisions regarding hypothesis-driven biological study. In the lack of an experimentally established framework, homology modeling can provide a rational alternative to a reasonable 3D structure. Knowledge of the 3D structure of these receptors is important for understanding the underlying molecular mechanisms of diseases caused.